Lithium Ion

Lithium Ion

SCHEMBL699991

CCn1nc(CN[C@@H]2CN3CCC2CC3)c2c(C(=O)[O-])cccc21.[Li+]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 3/20 0.42
GAA P10253 1/20 0.38
CYP1A2 P05177 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
ADRA2A P08913 1/20 0.37
CYP2D6 P10635 1/20 0.37
CHRM1 P11229 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
ADRA2B P18089 1/20 0.37
CHRM3 P20309 1/20 0.37
HTR1D P28221 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR4 Q13639 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL702370 1.00 HTR3A (0.42) HTR3AGAACYP1A2CHRM2CHRM4
Lithium Ion SCHEMBL700328 0.91 HTR3A (0.41) HTR3ACYP1A2CHRM2CHRM4ADRA2A
SCHEMBL4311862 0.90 HTR3A (0.43) HTR3AGAA
SCHEMBL4311857 0.90 HTR3A (0.43) HTR3AGAA
SCHEMBL4322855 0.90 HTR3A (0.43) HTR3AGAA
Lithium Ion SCHEMBL701408 0.90 HTR3A (0.36) HTR3AGAACYP1A2CHRM2CHRM4
SCHEMBL699992 0.90 HTR3A (0.42) HTR3AGAA
SCHEMBL699989 0.89 HTR3A (0.42) HTR3ACYP1A2CHRM2CHRM4ADRA2A
SCHEMBL699988 0.89 HTR3A (0.42) HTR3ACYP1A2CHRM2CHRM4ADRA2A
SCHEMBL701344 0.89 HTR3A (0.42) HTR3ACYP1A2CHRM2CHRM4ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124600-B2 5-HT3 receptor modulators, methods of making, and use thereof ALBANY MOLECULAR RESEARCH, INC. (US) 2012-02-28 US disclosed